EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia

Zhen Dong, Hugo Sepulveda, Leo J Arteaga-Vazquez, Chad Blouin, Jenna Fernandez, Moritz Binder, Wen-Chien Chou, Hwei-Fang Tien, Mrinal M Patnaik, Geoffrey J Faulkner, Samuel A Myers, Anjana Rao iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2413302121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Zhen Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037. Hauptthemen laut MEDLINE: Heterochromatin, Repressor Proteins, Clonal Hematopoiesis, Mutation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Pew Charitable Trusts, NIH HHS, NSC Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ASXL transcriptional regulator 1 (ASXL1) is one of the three most frequently mutated genes in age-related clonal hematopoiesis (CH), alongside DNA methyltransferase 3 alpha (DNMT3A) and Tet methylcytosine dioxygenase 2 ( TET2) . CH can progress to myeloid malignancies including chronic monomyelocytic leukemia (CMML) and is also strongly associated with inflammatory cardiovascular disease and all-cause mortality in humans. DNMT3A and TET2 regulate DNA methylation and demethylation pathways, respectively, and loss-of-function mutations in these genes reduce DNA methylation in heterochromatin, allowing derepression of silenced elements in heterochromatin. In contrast, the mechanisms that connect mutant ASXL1 and CH are not yet fully understood. CH/CMML-associated ASXL1 mutations encode C-terminally truncated proteins that enhance the deubiquitinase activity of the ASXL-BAP1 “PR-DUB” deubiquitinase complex, which removes monoubiquitin from H2AK119Ub. Here, we show that ASXL1 mutant proteins interact with the euchromatic histone lysine methyltransferases 1 and 2 (EHMT1–EHMT2) complex, which generates H3K9me1 and me2, the latter a repressive modification in constitutive heterochromatin. Compared to cells from age-matched wild-type mice, we found that expanded myeloid cells from old (≥18-mo-old) Asxl1tm/+ mice, a heterozygous knock-in mouse model of CH, display genome-wide decreases of H3K9me2, H3K9me3, and H2AK119Ub as well as an associated increase in expression of transposable elements (TEs) and satellite repeats. Increased TE expression was also observed in monocytes from ASXL1 -mutant CMML patients compared to monocytes from healthy controls. Our data suggest that mutant ASXL1 proteins compromise the integrity of both constitutive and facultative heterochromatin in an age-dependent manner by reducing the levels of H3K9me2/3 and H2AK119Ub. This increase in TE expression correlated with increased expression of nearby genes, including many interferon-inducible (inflammation-associated) genes (ISGs).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeterochromatinRepressor ProteinsClonal HematopoiesisMutationUbiquitin ThiolesteraseAnimalsMiceHumansDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDNA MethylationLeukemia, Myelomonocytic, ChronicDioxygenasesTumor Suppressor ProteinsDNA-Binding Proteins

Stichwörter der Autor:innen

CMMLEHMT1/2 (GLP/G9a)clonal hematopoiesisheterochromatinpolycomb response-deubiquitinase (PR-DUB) complex

Substanzen

HeterochromatinRepressor ProteinsAsxl1 protein, mouseASXL1 protein, humanUbiquitin ThiolesteraseDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDioxygenasesDnmt3a protein, mouseTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
  • Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037.
  • Department of Pharmacology, University of California, San Diego, CA 92161.
  • Division of Cancer Biology, Moores Cancer Center, San Diego, CA 92037.
  • Laboratory of Transcription and Epigenetics, Institute of Biomedical Sciences (ICB), Faculty of Medicine & Faculty of Life Sciences, Universidad Andres Bello, Santiago 7591358, Chile.
  • Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905.

ORCID-Profile: Anjana Rao

Förderung

  • The Pew Charitable Trusts
  • NIH HHS
  • NSC Taiwan
  • NCRR NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)
  • NCI NIH HHS
  • DHAC | NHMRC | National Institute for Dementia Research (NNIDR)
  • DHAC | National Health and Medical Research Council (NHMRC)

Zitieren

APA

Dong, Z., Sepulveda, H., Arteaga-Vazquez, L. J., Blouin, C., Fernandez, J., Binder, M., Chou, W. C., Tien, H. F., Patnaik, M. M., Faulkner, G. J., Myers, S. A., & Rao, A. (2025). A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2413302121

Vancouver

Dong Z, Sepulveda H, Arteaga-Vazquez LJ, Blouin C, Fernandez J, Binder M, et al. A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2413302121

BibTeX
@article{Dong2025,
  author = {Dong, Zhen and Sepulveda, Hugo and Arteaga-Vazquez, Leo J and Blouin, Chad and Fernandez, Jenna and Binder, Moritz and Chou, Wen-Chien and Tien, Hwei-Fang and Patnaik, Mrinal M and Faulkner, Geoffrey J and Myers, Samuel A and Rao, Anjana},
  title = {A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2413302121}
}
Kostenlos starten →